Insulin aspart, recombinant Subcutaneous and Olaparib Capsules
Determining the interaction of Insulin aspart, recombinant Subcutaneous and Olaparib Capsules and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
Generic Name: olaparib
Brand name: Lynparza
Synonyms: Olaparib
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin aspart, recombinant Subcutaneous-Olaparib Tablets
- Insulin aspart, recombinant Subcutaneous-Olaratumab
- Insulin aspart, recombinant Subcutaneous-Olaratumab Intravenous
- Insulin aspart, recombinant Subcutaneous-Oleptro
- Insulin aspart, recombinant Subcutaneous-Oleptro Oral
- Insulin aspart, recombinant Subcutaneous-Olmesartan
- Olaparib Capsules-Insulin degludec
- Olaparib Capsules-Insulin Degludec (U-100) Prefilled Pens
- Olaparib Capsules-Insulin Degludec (U-100) Vials
- Olaparib Capsules-Insulin Degludec (U-200) Prefilled Pens
- Olaparib Capsules-Insulin degludec and liraglutide
- Olaparib Capsules-Insulin degludec and liraglutide Subcutaneous